Targeted therapies in non-small cell lung cancer and their cardiovascular impact: mechanisms, clinical profiles, and strategies of management.

Saved in:
Bibliographic Details
Title: Targeted therapies in non-small cell lung cancer and their cardiovascular impact: mechanisms, clinical profiles, and strategies of management.
Authors: Nardin S; Division of Medical Oncology, Maggiore University Hospital, Novara, Italy.; Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy., Vezzoli F; Division of Medical Oncology, Maggiore University Hospital, Novara, Italy.; Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Cognolato G; Division of Medical Oncology, Maggiore University Hospital, Novara, Italy.; Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Mollace R; Cardiology Unit, Humanitas Gavazzeni, Bergamo, Italy.; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy., Ramella Pollone B; Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.; U.O. Clinica di Oncologia Medica, IRCCS Azienda Ospedaliera Metropolitana, Genoa, Italy., Biello F; Division of Medical Oncology, Maggiore University Hospital, Novara, Italy., Cao D; Cardiology Unit, Humanitas Gavazzeni, Bergamo, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Tagliamento M; Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.; U.O. Clinica di Oncologia Medica, IRCCS Azienda Ospedaliera Metropolitana, Genoa, Italy., Sarocchi M; Cardiovascular Disease Unit, IRCCS San Martino Policlinic Hospital, Genova, Italy., Pagnesi M; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Institute of Cardiology, ASST Spedali Civili, University of Brescia, Brescia, Italy., Verdoia M; Division of Cardiology, Nuovo Ospedale degli Infermi, ASL Biella, Biella, Italy., Conte B; Division of Medical Oncology, Maggiore University Hospital, Novara, Italy.; Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Grisanti S; Medical Oncology Unit, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy., Genova C; Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.; U.O. Clinica di Oncologia Medica, IRCCS Azienda Ospedaliera Metropolitana, Genoa, Italy., Gennari A; Division of Medical Oncology, Maggiore University Hospital, Novara, Italy.; Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Nardin M; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.; Internal Medicine, Department of Medicine, ASST Spedali Civili di Brescia, Brescia, Italy.
Source: Frontiers in pharmacology [Front Pharmacol] 2026 Mar 19; Vol. 17, pp. 1790897. Date of Electronic Publication: 2026 Mar 19 (Print Publication: 2026).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1663-9812
DOI:10.3389/fphar.2026.1790897